This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jemal A et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55: 10–30
Carter HB et al. (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267: 2215–2220
D'Amico AV et al. (2004) Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351: 125–135
D'Amico AV et al. (2005) Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA 294: 440–447
Freedland SJ et al. (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294: 433–439
Acknowledgements
The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Freedland, S. Can we preoperatively identify men who are at high risk for aggressive prostate cancer?. Nat Rev Urol 2, 584–585 (2005). https://doi.org/10.1038/ncpuro0355
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0355
This article is cited by
-
Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment
Cancer and Metastasis Reviews (2019)